Teranishi, Ryugo
Takahashi, Tsuyoshi http://orcid.org/0000-0003-2397-1478
Sato, Shinsuke
Sakurai, Katsunobu
Kishi, Kentaro
Hosogi, Hisahiro
Nakai, Takuya
Kurokawa, Yukinori
Fujita, Junya
Nishida, Toshirou
Hirota, Seiichi
Tsujinaka, Toshimasa
Funding for this research was provided by:
Osaka University
Article History
Received: 14 June 2023
Accepted: 19 October 2023
First Online: 25 December 2023
Declarations
:
: Tsuyoshi Takahashi received Honoraria from Pfizer, Bayer Yakuhin, Ltd, Taiho Pharmaceutical, Nippon Kayaku and Sawai Pharmaceutical Co., Ltd. outside the submitted work, and received the payment from Taiho Pharmaceutical. Toshirou Nishida reports Honoraria from Pfizer, Taiho Pharmaceutical and Eisai Co. outside the submitted work. Other authors declare that they have no conflict of interest.
: The Human Ethics Review Committee of the Osaka University Graduate School of Medicine approved the protocol for this retrospective study (Approval No. 18424-2). All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions.
: Informed consent to be included in the study, or the equivalent, was obtained from all patients.
: Consent for publication was obtained from all individuals whose data appears in the paper.